Dermatitis News

Patients with atopic diseases may be at an increased risk for developing osteoarthritis, according to data published in Annals of the Rheumatic Diseases.

A 4 mg dose of baricitinib was associated with significant improvement over placebo in a number of efficacy parameters in patients with moderate to severe atopic dermatitis, according to a study.

Zerigo Health announced the launch of Zerigo 2.0 ecosystem, a digital platform that connects health care systems and patients to the management and phototherapy treatment of chronic skin conditions, according to a company press release.

Atopic dermatitis is associated with atopic and nonatopic comorbidities as well as ocular, psychiatric, infectious, endocrine, autoimmune and cardiovascular diseases, in addition to some cancers, according to a review.

Compared with adults, upadacitinib exhibited similar efficacy and safety results in adolescents aged 12 to 17 years in the treatment of moderate to severe atopic dermatitis, according to a study.

The validated IGA for atopic dermatitis tool proved to be a reliable and accurate means to assess disease severity and quality of life among adults, adolescents and pediatric patients, according to a study.

The FDA has accepted for review a new drug application for roflumilast foam 0.3% for seborrheic dermatitis treatment in patients aged 9 years and older, Arcutis announced in a press release.

NEW ORLEANS — In an analysis of psoriasis and eczema patients, psycho-cognitive factors proved to impact quality of life more than objective disease severity.

Patients with atopic dermatitis treated with dupilumab did not experience any significantly increased risk for a primary or recurrent malignancy, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The use of topical corticosteroids to treat atopic dermatitis in infants also may help prevent hen’s egg allergy, but it may inhibit the baby’s growth as well, according to a study published in The Journal of Allergy & Clinical Immunology.